Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
7,847.00
-41.00 (-0.52%)
Sep 18, 2025, 9:30 AM IST
NSE:APOLLOHOSP Revenue
Apollo Hospitals Enterprise had revenue of 58.42B INR in the quarter ending June 30, 2025, with 14.88% growth. This brings the company's revenue in the last twelve months to 225.51B, up 14.31% year-over-year. In the fiscal year ending March 31, 2025, Apollo Hospitals Enterprise had annual revenue of 217.94B with 14.35% growth.
Revenue (ttm)
225.51B
Revenue Growth
+14.31%
P/S Ratio
5.03
Revenue / Employee
5.31M
Employees
42,497
Market Cap
1,134.17B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 217.94B | 27.35B | 14.35% |
Mar 31, 2024 | 190.59B | 24.47B | 14.73% |
Mar 31, 2023 | 166.13B | 19.50B | 13.30% |
Mar 31, 2022 | 146.63B | 41.03B | 38.85% |
Mar 31, 2021 | 105.60B | -6.87B | -6.11% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |
Aurobindo Pharma | 320.25B |
Apollo Hospitals Enterprise News
- 3 days ago - Top stocks to watch today, September 15: Apollo Hospitals, Vedanta, Tata Technologies, SRF, JSW Energy and more - Business Upturn
- 3 days ago - Stocks in news today, Sept 15: HUL, HAL, Dr Reddy’s, Apollo Hospitals, Adani Power, APL, Engineers India, Railtel among key shares - Business Upturn
- 3 days ago - Nomura maintains neutral on Apollo Hospitals with Rs 6,856 target price, sees greater flexibility from AHLL consolidation - Business Upturn
- 5 days ago - Apollo Hospitals to acquire IFC’s 31% stake in AHLL for Rs 1,254 cr - The Times of India
- 5 days ago - Apollo Hospitals to acquire IFC’s stake in Apollo Health & Lifestyle, plans new oncology centre in Gurugram - Business Upturn
- 9 days ago - Why the Sengottaiyan problem can harm EPS more than anything - The Times of India
- 11 days ago - CBI chief hospitalised in Hyd after chest pain - The Times of India
- 13 days ago - Nifty 50 top gainers today, September 4: Mahindra, Bajaj Finance, Apollo Hospitals, Bajaj Finserv and more - Business Upturn